Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of NovaDerm in burn patients

Next Previous
Trial Profile

Study of NovaDerm in burn patients

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 20 Jan 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Human skin replacement-Regenicin (Primary)
  • Indications Burns
  • Focus Adverse reactions
  • Sponsors Regenicin

    • Most Recent Events

    • 18 Jan 2017 According to a Regenicin media release, companay is planning to Schedule 10 subjects at two burn centers. Grafting will be performed on subjects in this trial in 2017.
    • 01 Nov 2016 According to a Regenicin Inc. media release, the company has completed pre-IND meeting with the FDA Office of Cellular, Tissue, and Gene Therapies (OCTGT) in the Center for Biologics Evaluation and Research (CBER) on October 27th, 2016 regarding NovaDerm.
    • 12 Oct 2016 According to a Regenicin Inc., media release the company has scheduled a Pre-IND meeting with FDA Office on 27th Oct 2016 regarding the development of NovaDerm.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top